Notice of Early Expiration of RFA-EB-22-002, "HEAL Initiative: Translational Development of Diagnostic and Therapeutic Devices (R18 Clinical Trial Not Allowed)" | 11 Academia Networks
Skip to main content
Publish
Home
The Power of Niche Career Hubs
  • Publish
  • Login
  • Create Account
The Power of Niche Career Hubs
LinkedIn
Facebook
BlueSky
Reddit
X
Share Options
Share Options
Whatsapp
Threads
Email
LinkedIn
Facebook
BlueSky
Reddit
X
Whatsapp
Threads
Email

Notice of Early Expiration of RFA-EB-22-002, "HEAL Initiative: Translational Development of Diagnostic and Therapeutic Devices (R18 Clinical Trial Not Allowed)"

National Institutes of Health
Type

Research/project funding

Posted on

17 April 2025

Notice NOT-EB-25-001 from the NIH Guide for Grants and Contracts

More Information

Visit Website

Type

Research/Project Funding

Posted on

17 April 2025

Turn On Deadline Reminders

, United States

  • nih guide
  • early expiration
  • rfa-eb-22-002
  • scholarship
  • r18 clinical trial
  • translational development
  • diagnostic
  • national institutes of health

    Also Interesting

    • Research/Project Funding Opportunity

    Notice of Change to PAR-23-065 NIAID Resource-Related Research Projects (R24 Clinical Trial Not Allowed)

    • Research/Project Funding Opportunity

    Notice of Early Expiration of PAR-24-055 "Single Source: The NIGMS Human Genetic Cell Repository (U42 - Clinical Trial Not Allowed)"

    • Research/Project Funding Opportunity

    Notice of Early Expiration of PAR-23-300, "Global Infectious Disease Research Administration Development Award for Low-and Middle-Income Country Institutions (G11 Clinical Trial Not Allowed)"

Links

Footer menu

  • Our Story
  • Advertise
  • Careers
  • Contact
  • Help
  • Partners
  • References
  • Terms & Conditions

Customer Support

+49 (0)30 - 2084712 50
info@11academianetworks.com

Language

Copyright © 2016-2025 11 Academia Networks. All rights reserved

×

Login to your account

Email Address

Password

Forgot your password? Click here.

Google
Login with Google
or